E-LIB Suche - Ergebnisse für: Durán, Soledad

1

Response‐adapted treatment with rituximab, bendamustine, mi..:

Peñalver, Francisco‐Javier ; Márquez, José‐Antonio ; Durán, Soledad...
Cancer Medicine. 8 (2019) 16 - p. 6955-6966 , 2019

Link: https://doi.org/10.1002/..

2

Evaluation of Clinical and Biological Prognostic Factors in..:

Panizo, Carlos ; Rodríguez, Anny Jaramillo ; Gutiérrez, Gonzalo...
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) 7 - p. 398-403 , 2015

Link: https://doi.org/10.1016/..

3

Evaluation of tolerability and efficacy of imatinib mesylat..:

Sánchez-Guijo, Fermin M. ; Durán, Soledad ; Galende, Josefina...
Leukemia Research. 35 (2011) 9 - p. 1184-1187 , 2011

Link: https://doi.org/10.1016/..

4

P-115: Renal response to rescue treatments in Relapsed Refr..:

Garcia-Guiñón, Antonio ; Morales, Enrique ; Sureda, A...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S97-S98 , 2021

Link: https://doi.org/10.1016/..

5

Multiple Myeloma Treatment in Real-world Clinical Practice:..:

Mohty, Mohamad ; Terpos, Evangelos ; Mateos, Maria-Victoria...
Clinical Lymphoma Myeloma and Leukemia. 18 (2018) 10 - p. e401-e419 , 2018

Link: https://doi.org/10.1016/..

6

Evolution of iron overload in patients with low-risk myelod..:

On behalf of the IRON-2 Study Group ; Remacha, Ángel F. ; Arrizabalaga, Beatriz...
Annals of Hematology. 94 (2014) 5 - p. 779-787 , 2014

Link: https://doi.org/10.1007/..

7

Salud oral en adolescentes: Escuelas saludables:

Canchari Pereyra, Teresa Paola ; Cortez Beltrán, Leonardo Augusto ; Rojas Claros, Andrea María José...
Revista Científica de Salud UNITEPC. 9 (2022) 1 - p. 49-55 , 2022

Link: https://doi.org/10.36716..

8

Response‐adapted treatment with rituximab, bendamustine, mi..:

Peñalver, Francisco‐Javier ; Márquez, Jose‐Antonio ; Durán, Soledad...
Cancer Medicine;8(16). , 2019

Link: https://hdl.handle.net/1..

9

Response‐adapted treatment with rituximab, bendamustine, mi..:

Peñalver, Francisco‐Javier ; Márquez, José‐Antonio ; Durán, Soledad...
2045-7634. , 2019

Link: http://hdl.handle.net/10..

10

Response‐adapted treatment with rituximab, bendamustine, mi..:

Peñalver, Francisco‐Javier ; Márquez, José‐Antonio ; Durán, Soledad...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853826/. , 2019

Link: http://www.ncbi.nlm.nih...

11

Response-adapted treatment with rituximab, bendamustine, mi..:

Peñalver, Francisco-Javier ; Márquez, José-Antonio ; Durán, Soledad...
http://hdl.handle.net/10668/14572. , 2019

Link: http://hdl.handle.net/10..

12

Response-adapted treatment with rituximab, bendamustine, mi..:

Peñalver, Francisco-Javier ; Márquez, José-Antonio ; Durán, Soledad...
Peñalver FJ, Márquez JA, Durán S, Giraldo P, Martín A, Montalbán C. et al. Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular Llymphoma after first-line immunochemotherapy: results of the RBMDGELTAMO08 phase II trial. Cancer Med. 2019 Nov;8 (16):6955-66. DOI:10.1002/cam4.2555. ,

Link: http://hdl.handle.net/10..

13

International Sentinel Site Surveillance of Patients with T..:

El-Beshlawy, Amal ; Inusa, Baba ; Beneitez, David...
Clinical Lymphoma Myeloma and Leukemia. 16 (2016) - p. S85 , 2016

Link: https://doi.org/10.1016/..

14

Do chronic myeloid leukemia patients with late "warning" re..:

García‐Gutiérrez, Valentin ; Puerta, Jose Manuel ; Maestro, Begoña...
American Journal of Hematology. 89 (2014) 11 - p. , 2014

Link: https://doi.org/10.1002/..

15

Medición del capital humano de la empresa: el caso Efigas:

Naranjo Herrera, Cristhian Guillermo ; Durán Pinzón, Érika Soledad ; Escobar Bautista, Claudia Marcela
Equidad y Desarrollo. , 2013

Link: https://doi.org/10.19052..